Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Carboplatin
Drug ID BADD_D00364
Description Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma.[L32253] Early clinical studies of carboplatin were performed in 1982.[A230523] Carboplatin was developed as an analog of [cisplatin] with reduced nephrotoxicity and vomiting.[A230463,A230523] Carboplatin was granted FDA approval on 3 March 1989.[L32248]
Indications and Usage For the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of PARAPLATIN and cyclophosphamide. It is also indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.
Marketing Status Prescription; Discontinued
ATC Code L01XA02
DrugBank ID DB00958
KEGG ID D01363
MeSH ID D016190
PubChem ID 426756
TTD Drug ID D0X7HM
NDC Product Code 0703-4239; 55150-335; 63592-0271; 68083-192; 49812-0010; 68554-0084; 53104-7570; 69448-005; 0703-4246; 54875-0002; 55150-386; 55150-334; 0703-4248; 55150-333; 63323-172; 72659-863; 68083-191; 71288-100; 16729-295; 0703-4244; 68083-193; 68083-190; 61703-339
Synonyms Carboplatin | cis-Diammine(cyclobutanedicarboxylato)platinum II | CBDCA | Paraplatin | Paraplatine | Platinwas | Ribocarbo | Carboplat | Neocarbo | Carbosin | Carbotec | Ercar | JM-8 | JM 8 | JM8 | Nealorin | NSC-241240 | NSC 241240 | NSC241240 | Blastocarb
Chemical Information
Molecular Formula C6H12N2O4Pt
CAS Registry Number 41575-94-4
SMILES C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acute myelomonocytic leukaemia01.10.05.005; 16.01.05.0050.000139%Not Available
Arterial rupture24.03.02.027; 12.01.11.0100.000533%Not Available
Bladder sphincter atony20.03.03.006; 17.05.01.0230.001332%Not Available
Blood pressure immeasurable13.14.03.0260.001332%Not Available
Bronchial fistula22.03.02.0110.000799%
Cardiac failure chronic02.05.01.0090.000139%Not Available
Cellulitis orbital06.04.11.001; 11.02.01.0350.001865%Not Available
Culture stool positive13.08.02.0060.000799%Not Available
Culture urine positive13.08.02.0070.000533%Not Available
Full blood count decreased13.01.07.004--Not Available
Lung adenocarcinoma22.08.01.007; 16.19.01.0020.000278%Not Available
Lymphadenopathy mediastinal22.09.03.006; 01.09.01.0250.000533%Not Available
Malignant pleural effusion22.05.04.001; 16.32.03.0140.000139%Not Available
Metastases to bone16.22.02.005; 15.09.03.0060.002398%Not Available
Metastases to lymph nodes16.22.02.006; 01.09.01.0150.000208%Not Available
Mixed deafness04.02.01.014; 17.04.07.0060.000799%Not Available
Pancreatic carcinoma metastatic16.13.10.003; 07.21.09.0060.000208%Not Available
Pulmonary artery thrombosis24.01.06.005; 22.06.02.0050.000799%Not Available
Recurrent cancer16.16.01.0150.000533%Not Available
Seminoma21.13.02.004; 16.25.03.0020.000533%Not Available
Systemic sclerosis23.03.02.021; 15.06.01.019; 10.04.07.006; 07.11.02.008; 24.03.03.0410.000208%Not Available
Pericardial effusion malignant16.32.03.026; 02.06.01.0090.000533%Not Available
Pneumocephalus17.02.05.060; 12.02.04.0090.000533%Not Available
Metastases to meninges17.02.10.012; 16.22.02.0030.000208%Not Available
Enterobacter infection11.02.09.0020.001066%Not Available
Brain natriuretic peptide increased13.02.04.0110.001332%Not Available
Laryngeal discomfort22.02.05.0400.000533%Not Available
Superior mesenteric artery syndrome24.03.03.040; 07.13.06.0090.001332%Not Available
Clostridium difficile infection11.02.02.0090.001066%Not Available
Thyroid cancer metastatic16.24.03.006; 05.02.05.0090.000139%Not Available
The 24th Page    First    Pre   24 25    Next   Last    Total 25 Pages